Adverum Biotechnologies to Participate in the Cowen 45th Annual Health Care Conference Feb 25, 2025 07:00AM
TD Cowen Reiterates Buy Rating on Adverum Biotechnologies (ADVM) Aug 13, 2024 09:28AM
TD Cowen Reiterates Buy Rating on Adverum Biotechnologies (ADVM) Jul 17, 2024 12:00PM
Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit Jun 18, 2024 08:00AM
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference Feb 28, 2024 04:05PM


Feb 5, 2024 07:45AM Adverum Biotechnologies (ADVM) Announces 106.25M Share Private Placement at $1.20/sh
Feb 5, 2024 07:45AM Adverum Biotechnologies Announces $127.5 Million Private Placement Financing
Feb 27, 2023 04:05PM Adverum Biotechnologies to Present at Upcoming Investor Conferences
Feb 28, 2022 08:00AM Adverum Biotechnologies to Participate in the 42nd Annual Cowen Healthcare Conference
Aug 18, 2020 09:00AM Adverum Biotechnologies Announces Closing of $217 Million Public Offering of Common Stock
Aug 13, 2020 05:57AM Adverum Biotechnologies (ADVM) Prices 14.5M Share Common Offering at $13/Sh
Aug 12, 2020 09:37PM Adverum Biotechnologies Announces Pricing of Public Offering of Common Stock
Aug 11, 2020 04:02PM Adverum Biotechnologies (ADVM) Announces $200M Common Share Offering
Aug 11, 2020 04:01PM Adverum Biotechnologies Announces $200 Million Public Offering of Common Stock
Feb 19, 2020 04:01PM Adverum Biotechnologies to Present at Upcoming Investor Conferences
Feb 14, 2020 04:01PM Adverum Biotechnologies Announces Closing of $150 Million Public Offering of Common Stock
Feb 12, 2020 05:50AM Adverum Biotechnologies (ADVM) Prices 9.5M Share Common Offering at $13.75/Sh
Feb 11, 2020 08:27PM Adverum Biotechnologies Announces Pricing of Public Offering of Common Stock
Feb 10, 2020 04:02PM Adverum Biotechnologies (ADVM) to Offer $100M in Stock
Feb 10, 2020 04:01PM Adverum Biotechnologies Announces $100 Million Public Offering of Common Stock
Mar 6, 2019 04:10PM Adverum Biotechnologies Reports Fourth Quarter 2018 Financial Results and Provides Corporate Update
Feb 28, 2019 04:10PM Adverum to Present at the Cowen 39th Annual Health Care Conference
Jan 6, 2019 08:00PM Adverum Biotechnologies Provides 2019 Outlook
Mar 6, 2018 04:00PM Adverum Biotechnologies Reports Fourth Quarter 2017 Financial Results and Provides Corporate Update
Feb 26, 2018 09:01AM Adverum Biotechnologies to Present at Upcoming Investor Conferences
Feb 12, 2018 04:01PM Adverum Biotechnologies Announces Closing of $69 Million Public Offering
Feb 8, 2018 08:13AM Adverum Biotechnologies (ADVM) Prices 8.89M Common Stock Offering at $6.75/Share
Feb 8, 2018 08:00AM Adverum Biotechnologies Announces Pricing of $60 Million Public Offering of Common Stock
Feb 7, 2018 04:02PM Adverum Biotechnologies (ADVM) to Offer Common Stock
Feb 7, 2018 04:01PM Adverum Biotechnologies Announces Proposed Public Offering of Common Stock
Jan 4, 2018 09:02AM Adverum Biotechnologies (ADVM) Announces Progress Update and 2018 Outlook
Jan 4, 2018 09:00AM Adverum Biotechnologies Provides 2018 Outlook
Mar 6, 2017 09:00AM Adverum Biotechnologies Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Update
Feb 21, 2017 08:30AM Adverum Biotechnologies to Present at Upcoming Investor Conferences
May 27, 2016 08:03AM Cowen Reinstates Adverum Biotechnologies (ADVM) at Outperform